|4Jul 19, 7:32 PM ET

MDB CAPITAL GROUP LLC 4

4 · Provention Bio, Inc. · Filed Jul 19, 2018

Insider Transaction Report

Form 4
Period: 2018-07-19
Transactions
  • Conversion

    Warrant to Purchase Common Stock (right to buy)

    2018-07-19+274,289274,289 total
    Exercise: $2.50From: 2018-07-19Exp: 2024-04-25Common Stock (274,289 underlying)
  • Other

    Warrant to Purchase Common Stock (right to buy)

    2018-07-19+1,596,9561,871,245 total
    Exercise: $5.00From: 2019-06-28Exp: 2023-06-28Common Stock (1,596,956 underlying)
  • Conversion

    Warrant to Purchase Preferred Stock (right to buy)

    2018-07-19274,2890 total
    Exercise: $2.50From: 2017-04-25Exp: 2024-04-25Common Stock (274,289 underlying)
Footnotes (2)
  • [F1]Warrant to purchase shares of Series A Preferred Stock initially issued to Reporting Person on April 25, 2017 as partial compensation for Reporting Person acting as placement agent in connection with Issuer's private placement of Series A Preferred Stock. Warrant automatically converted into a warrant to purchase the same number of shares of the Issuer's Common Stock immediately after the closing of the Issuer's Initial Public Offering on July 19, 2018.
  • [F2]Warrant issued to Reporting Person as partial compensation for Reporting Person acting as underwriter in connection with Issuer's Initial Public Offering.

Documents

1 file
  • 4
    ownership.xmlPrimary